|Fees to non-executive directors||0.7||0.6|
|Share-based payment charge||1.5||1.0|
Further information about the remuneration of individual directors and details of their pension arrangements are provided in the directors' remuneration report.
Remuneration of key management personnel
|Salaries and short-term employee benefits||5.5||4.9|
|Share-based payment charge||2.6||1.8|
Key management personnel comprises all directors and certain senior managers who are members of the executive team.
Employee benefits expense (including directors)
|Wages and salaries||219.9||212.7|
|Defined benefit pension expense (see note 18)||25.5||26.1|
|Defined contribution pension expense (see note 18)||11.2||9.9|
|Charged to regulatory capital schemes||(129.4)||(120.7)|
|Amounts recharged to related parties at nil margin under transitional service agreements (see note A5)||(4.0)||–|
|Employee benefits expense||151.9||146.9|
Within employee benefits expense were £10.1 million (2016: £0.9 million) of restructuring costs.
The total expense included within employee benefits expense in respect of equity-settled share-based payments was £3.4 million (2016: £2.3 million). The company operates several share option schemes in the directors' remuneration report. Further disclosures have not been included as they are considered immaterial to the assessment of the share-based payments charge.
Average number of employees during the year (full-time equivalent including directors):
|Average number of employees during the year||5,310||5,265|
The company has no employees.